Surgical Clinic, Clinical-Hospital Centre Zvezdara, Nikola Spasić, Dimitrija Tucovića 161, 11000, Belgrade, Serbia.
Surg Today. 2011 Jun;41(6):767-73. doi: 10.1007/s00595-010-4364-3. Epub 2011 May 28.
A new method for ensuring hemostasis during thyroid surgery has recently been introduced. This technique, electrothermal (LigaSure) and ultrasound blood vessel sealing, is still experimental. The aim of the present study was to evaluate the applications and efficacy of LigaSure by analyzing the duration of the surgery and the rate of complications of the surgical procedure.
A total of 23 patients who underwent the LigaSure operation (n(LS) group) were analyzed in a prospective nonrandomized/partly randomized clinical study, and were compared with patients who underwent treatment using the conventional (ligature) surgical technique.
At our institutions, 187 patients were treated surgically for thyroid disease in 2006, and 23 of these patients were treated using LigaSure. The complication rate in the patients treated with LigaSure (n(LS): 4.3%) was lower than those who received conventional ligature surgery. However, given the small number of patients, this difference was not statistically significant (retrospective group n(1): 10.7%; nonrandomized group n(2): 9.8%; and randomized group n(3): 9.1%). The length of surgery in the LigaSure group (n(LS) = 65 ± 3 min) was significantly shorter (P < 0.001) compared with both nonrandomized (n(2) = 71 ± 6 min) and randomized (n(3) = 70 ± 4 min) patients who received a conventional ligature.
The application of LigaSure using meticulous surgical technique provides a new option for a safe thyroidectomy. Moreover, the duration of the LigaSure procedure is significantly shorter, and there are fewer complications as compared with the classic surgical thyroidectomy technique.
最近引入了一种新的甲状腺手术止血方法。该技术,即电热(LigaSure)和超声血管密封,仍处于实验阶段。本研究旨在通过分析手术持续时间和手术过程并发症的发生率来评估 LigaSure 的应用和疗效。
在一项前瞻性非随机/部分随机临床研究中,分析了 23 例接受 LigaSure 手术(n(LS)组)的患者,并与接受常规(结扎)手术治疗的患者进行了比较。
在我们的机构中,2006 年有 187 例甲状腺疾病患者接受了手术治疗,其中 23 例患者接受了 LigaSure 治疗。LigaSure 治疗组(n(LS):4.3%)的并发症发生率低于接受常规结扎手术的患者。然而,由于患者数量较少,这种差异没有统计学意义(回顾性组 n(1):10.7%;非随机组 n(2):9.8%;随机组 n(3):9.1%)。LigaSure 组(n(LS)=65±3min)的手术时间明显缩短(P<0.001),与非随机组(n(2)=71±6min)和随机组(n(3)=70±4min)相比。
使用精细手术技术应用 LigaSure 为安全的甲状腺切除术提供了一种新的选择。此外,与经典的甲状腺手术技术相比,LigaSure 手术的持续时间明显更短,并发症更少。